PWEAX
Price
$20.12
Change
-$0.39 (-1.90%)
Updated
Jun 10 closing price
Net Assets
570.92M
VEIEX
Price
$36.50
Change
-$0.51 (-1.38%)
Updated
Jun 10 closing price
Net Assets
162.82B
Interact to see
Advertisement

PWEAX vs VEIEX

Header iconPWEAX vs VEIEX Comparison
Open Charts PWEAX vs VEIEXBanner chart's image
PWEAX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
PWEAX vs. VEIEX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PWEAX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 163B vs. PWEAX (571M). VEIEX pays higher dividends than PWEAX: VEIEX (2.29) vs PWEAX (1.35). PWEAX was incepted earlier than VEIEX: PWEAX (26 years) vs VEIEX (32 years). PWEAX (1.61) is less costly to investors than VEIEX (0.29). PWEAX is a more actively managed with annual turnover of: 70.00 vs. VEIEX (6.00). VEIEX has a lower initial minimum investment than PWEAX: VEIEX (0) vs PWEAX (1000). PWEAX annual gain was more profitable for investors over the last year : 42.53 vs. VEIEX (21.68). PWEAX return over 5 years is better than : 21.71 vs. VEIEX (18.18).
PWEAXVEIEXPWEAX / VEIEX
Total Expense Ratio1.450.29500%
Annual Report Gross Expense Ratio1.610.29555%
Fund Existence26 years32 years-
Gain YTD21.8668.853247%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets571M163B0%
Annual Yield % from dividends1.352.2959%
Returns for 1 year42.5321.68196%
Returns for 3 years72.2952.50138%
Returns for 5 years21.7118.18119%
Returns for 10 years116.83100.24117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLW16.550.25
+1.53%
Clearwater Paper Corp
PEBO36.060.45
+1.26%
Peoples Bancorp
BMO164.39-0.83
-0.50%
Bank of Montreal
TFX132.15-3.60
-2.65%
Teleflex
NRSN0.73-0.03
-3.78%
NeuroSense Therapeutics Ltd